Drug Database
SH
SH-U-454
✓ ApprovedBayer AG · Small Molecule · Small Molecule
What is SH-U-454?
SH-U-454 is a small molecule developed by Bayer AG. It is approved for therapeutic indications via injectable (others) or intravenous (iv).
Drug Profile
| Company | Bayer AG |
| Drug Class | Small Molecule, Imaging Agents |
| Route | Injectable (Others), Intravenous (IV) |
| Status | Approved |
Sources: ClinicalTrials.gov, Bayer AG
Therapeutic Indications
SH-U-454 is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Cardiac disorders | Arteriosclerosis coronary artery | ✓ Approved |
Related Research Articles
Unable to load articles right now.